Omeprazol Pensa (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Pensa, is a proton pump inhibitor (PPI) presented as a strength/form for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children. GNH USA supplies Omeprazol Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Pensa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Pensa is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of the esophageal lining. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced gastropathy: helps prevent ulcer formation in patients requiring long‑term NSAID therapy.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate headache reported in clinical use. - Diarrhea: loose stools occurring in a minority of patients. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Acute interstitial nephritis: inflammation of kidney interstitium. - Hypomagnesemia: low serum magnesium with prolonged use. - Stevens‑Johnson syndrome: rare severe skin reaction. - Fracture risk: possible increase in hip, wrist or spine fractures with long‑term therapy. - Liver enzyme elevation: abnormal liver function tests in some patients.

When prescribing Omeprazol Pensa, consider the following precautions: - Assess renal function: adjust use in patients with severe kidney impairment. - Evaluate hepatic status: use with caution in moderate to severe liver disease. - Review long‑term use: monitor for bone density loss and magnesium levels. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Drug interactions: check concomitant medications for possible PK/PD effects. - Store at ambient temperature: keep below 25°C, protect from moisture and light.

Omeprazole may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atazanavir: decreased absorption of atazanavir, compromising HIV therapy. - Dasatinib: lower plasma concentrations, reducing efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Phenytoin: reduced phenytogine (phenytoin) levels. - Ketamine: increased exposure to ketamine metabolites. - Digoxin: possible rise in serum digoxin concentration.